Standard BioTools
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Standard BioTools generated cash of -$43,287,000, which is more than the previous year. Cash used in financing activities reached the amount of -$6,809,000 last year. Net change in cash is therefore -$29,825,000.
Cash Flow
| 2014 | -22.62M | -178.38M | 200.32M |
|---|---|---|---|
| 2015 | -34.69M | 25.74M | 5.30M |
| 2016 | -39.09M | 45.10M | 76K |
| 2017 | -24.09M | 17.65M | 28.99M |
| 2018 | -25.20M | 4.71M | 57.66M |
| 2019 | -35.21M | -39.30M | 2.79M |
| 2020 | -15.41M | 39.97M | 20.85M |
| 2021 | -44.06M | -11.94M | 15.95M |
| 2022 | -89.37M | -88.12M | 230.75M |
| 2023 | -43.28M | 20.23M | -6.80M |
FLDM Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 82.32M | 29.46M | 69.53M | 23.73M | 95.40M | 58.05M | 35.04M | 29.11M | 33.71M | 35.26M |
Operating activities | ||||||||||
Net income | -74.65M | -190.09M | -59.23M | -53.02M | -64.79M | -59.01M | -60.53M | -75.98M | -53.31M | -52.83M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 15.18M | 15.02M | 15.57M | 15.92M | 15.80M | 16.57M | 18.60M | 17.93M | 16.11M | 4.06M |
Stock-based compensation expense | 13.12M | 14.88M | 16.10M | 14.45M | 11.39M | 0 | 9.09M | 13.85M | 16.83M | 20.94M |
| Deferred income tax benefit | 13.12M | 14.88M | 16.10M | 14.45M | 11.39M | 0 | 9.09M | 13.85M | 16.83M | 20.94M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -2.99M | 1.06M | 6.72M | -7.62M | -2.07M | -1.78M | -554K | 10.52M | -2.76M | -3.39M |
Inventories | -4.91M | -8.47M | -4.78M | -8.63M | -2.68M | 1.48M | 4.59M | -3.38M | -3.74M | -6.16M |
Accounts payable | 1.61M | -2.77M | 1.28M | 3.35M | 2.14M | -294K | 585K | -2.27M | 769K | 107K |
Cash generated by operating activities | -43.28M | -89.37M | -44.06M | -15.41M | -35.21M | -25.20M | -24.09M | -39.09M | -34.69M | -22.62M |
Investing activities | ||||||||||
Purchases Of Investments | -94.89M | -137.30M | 0 | 0 | -62.37M | -1.45M | -6.27M | -38.59M | -66.97M | -132.64M |
Investments In Property Plant And Equipment | -2.83M | -3.82M | -13.26M | -12.71M | -2.53M | -372K | -1.61M | -5.06M | -10.65M | -7.40M |
Acquisitions Net | 0 | 84.30M | 0 | -5.15M | 36.77M | 0 | 50K | 2.33M | -2.33M | -112.85M |
Cash generated by investing activities | 20.23M | -88.12M | -11.94M | 39.97M | -39.30M | 4.71M | 17.65M | 45.10M | 25.74M | -178.38M |
Financing activities | ||||||||||
Common Stock Issued | 0 | 0 | 1.49M | 20.22M | 2.13M | 59.46M | 28.79M | 76K | 5.30M | 78.19M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | -5.41M | -563K | -1.79M | -459K | -629K | 0 | 0 | 0 | -151K | 0 |
Repayments of term debt | -2.08M | 18.16M | -501K | 0 | 3.17M | 0 | 0 | 0 | 0 | 0 |
Cash used in financing activities | -6.80M | 230.75M | 15.95M | 20.85M | 2.79M | 57.66M | 28.99M | 76K | 5.30M | 200.32M |
Net Change In Cash | -29.82M | 52.85M | -40.06M | 45.8M | -71.66M | 37.34M | 23.01M | 5.92M | -4.59M | -1.54M |
Cash at end of period | 52.49M | 82.32M | 29.46M | 69.53M | 23.73M | 95.40M | 58.05M | 35.04M | 29.11M | 33.71M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |